Shiyu Capital Leads $278M Series A Round In Chinese Pharmaceutical Startup Mabwell

This Data Is Locked!

This area is available only to Subscribers.

Chinese venture capital firm Shiyu Capital has led a RMB1.97 billion (US$278.5 million) Series A financing round in Mabwell Biotech, a Shanghai-based innovative biopharmaceutical company.... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?